Tinea capitis in an immigrant pediatric community; a clinical signs-based treatment approach

Riad Kassem1,2, Yahel Shemesh3, Orna Nitzan3,4

  • 1Dermatology Department, Sheba Medical Center, Tel Aviv, Israel.

BMC Pediatrics
|August 27, 2021
PubMed
Abstract

Insights

Tinea capitis, a common scalp infection in African refugee children, often requires prompt treatment. Griseofulvin is recommended for effective management, preventing long-term damage and community outbreaks.

Area of Science:

  • Dermatology
  • Mycology
  • Pediatrics

Background:

  • Tinea capitis is a prevalent scalp infection, particularly in African refugee children in Israel, who show increased susceptibility.
  • Diagnosis typically involves direct examination and culture, with treatment often delayed pending mycology results.
  • Refugee children frequently miss follow-up appointments, complicating management.

Purpose of the Study:

  • To identify clinical characteristics and treatment responses of Tinea capitis in Israeli refugee children.
  • To establish a treatment plan for primary care physicians to manage this condition effectively.
  • To reduce diagnostic delays and prevent severe scalp damage or community spread.

Main Methods:

  • Retrospective analysis of demographic, clinical, and laboratory data from 76 refugee children with Tinea capitis (2016-2017).
  • Descriptive statistics were used for variable presentation.
  • Chi-squared, Wilcoxon, and T-tests assessed correlations between clinical, demographic, and laboratory data.

Main Results:

  • Scaling was the most frequent clinical presentation.
  • Tinea violaceum was the predominant fungal strain identified.
  • Fluconazole showed a 27% failure rate, while griseofulvin (50 mg/kg/day) demonstrated high efficacy with no reported side effects in 97% of treated children.

Conclusions:

  • Prompt diagnosis and treatment by pediatricians are crucial for immigrant children with scaly scalps, considering Tinea capitis as a primary diagnosis.
  • Griseofulvin at 50 mg/kg/day is recommended for initial treatment to prevent permanent scalp damage and systemic spread.
  • Early intervention by pediatricians can mitigate long-term complications and prevent community outbreaks.

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
274
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
43
Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
215
Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.9K
Methods of reducing fever01:22

Methods of reducing fever

The signs and symptoms of fever include hot and dry skin, flushed face, thirst, muscle aches, anorexia, headache, tachycardia, tachypnea, and fatigue. Elevated body temperature is reduced using two methods: pharmacological and nonpharmacological. Proper identification and treatment of the root cause of a fever is of utmost importance.
Pharmacological Methods of Reducing Fever:
908
Decreased Body Temperature01:29

Decreased Body Temperature

A decreased body temperature can occur in patients with hypothermia and frostbite. Heat loss with extended cold exposure overpowers the body's ability to create heat, resulting in hypothermia. Core temperature readings help classify hypothermia. Mild hypothermia is temperatures between 32 °C (89.6 °F) and 35°C (95 °F) and is caused by impaired thermoregulation. Moderate hypothermia is temperatures between 28 C (82.4 °F) and 32 °C (89.6 °F) caused by...
752